Cellular senescence and organismal aging

Mechanisms of Ageing and Development

Volumn 129, Issue 7-8, 2008, Pages 467-474

  Jeyapalan, Jessie C ^a   Sedivy, John M ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Aging; Cellular senescence; Telomeres

Indexed keywords

DNA;

AGING; ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CELL FUNCTION; CELL PROLIFERATION; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; GENE EXPRESSION; GENE MUTATION; HUMAN; LMNA GENE; MUTATOR GENE; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PHENOTYPE; PREMATURE AGING; PRIORITY JOURNAL; PROGERIA; PROSTATE HYPERTROPHY; STEM CELL; TELOMERE; UPREGULATION; WERNER SYNDROME; WRN GENE;

AGING; CELL AGING; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE; HUMANS; TELOMERE;

EID: 45449084795     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2008.04.001     Document Type: Article

References (181)

1. Adams J., Martin-Ruiz C., Pearce M.S., White M., Parker L., and von Zglinicki T. No association between socio-economic status and white blood cell telomere length. Aging Cell 6 (2007) 125-128
2. Adams P.D. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 397 (2007) 84-93
3. Allsopp R.C., Morin G.B., DePinho R., Harley C.B., and Weissman I.L. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 102 (2003) 517-520
4. Allsopp R.C., Morin G.B., Horner J.W., DePinho R., Harley C.B., and Weissman I.L. Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells. Nat. Med. 9 (2003) 369-371
5. Armanios M.Y., Chen J.J., Cogan J.D., Alder J.K., Ingersoll R.G., Markin C., Lawson W.E., Xie M., Vulto I., Phillips J.A.r., Lansdorp P.M., Greider C.W., and Loyd J.E. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356 (2007) 1317-1326
6. Aviv A., Valdes A.M., and Spector T.D. Human telomere biology: pitfalls of moving from the laboratory to epidemiology. Int. J. Epidemiol. 35 (2006) 1424-1429
7. Baerlocher G.M., Vulto I., de Jong G., and Lansdorp P.M. Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat. Protoc. 1 (2006) 2365-2376
8. Bavik C., Coleman I., Dean J.P., Knudsen B., Plymate S., and Nelson P.S. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res. 66 (2006) 794-802
9. Bayreuther K., Rodemann H.P., Francz P.I., and Maier K. Differentiation of fibroblast stem cells. J. Cell Sci. Suppl. 10 (1988) 115-130
10. Bierman E.L. The effect of donor age on the in vitro life span of cultured human arterial smooth-muscle cells. In Vitro 14 (1978) 951-955
11. Blasco M.A. Telomere length, stem cells and aging. Nat. Chem. Biol. 3 (2007) 640-649
12. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., and Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 279 (1998) 349-352
13. Boukamp P. Skin aging: a role for telomerase and telomere dynamics?. Curr. Mol. Med. 5 (2005) 171-177
14. Bracken A.P., Kleine-Kohlbrecher D., Dietrich N., Pasini D., Gargiulo G., Beekman C., Theilgaard-Monch K., Minucci S., Porse B.T., Marine J.C., Hansen K.H., and Helin K. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 21 (2007) 525-530
15. Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A.H., Schlegelberger B., Stein H., Dorken B., Jenuwein T., and Schmitt C.A. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436 (2005) 660-665
16. Brown W.T. Genetic diseases of premature aging as models of senescence. Annu. Rev. Gerontol. Geriatr. 10 (1990) 23-42
17. Bruce S.A., Deamond S.F., and Ts'o P.O. In vitro senescence of Syrian hamster mesenchymal cells of fetal to aged adult origin. Inverse relationship between in vivo donor age and in vitro proliferative capacity. Mech. Ageing Dev. 34 (1986) 151-173
18. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 (2005) 513-522
19. Campisi J., and d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8 (2007) 729-740
20. Canela A., Vera E., Klatt P., and Blasco M.A. High-throughput telomere length quantification by FISH and its application to human population studies. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 5300-5305
21. Castro P., Giri D., Lamb D., and Ittmann M. Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate 55 (2003) 30-38
22. Castro P., Xia C., Gomez L., Lamb D.J., and Ittmann M. Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia. Prostate 60 (2004) 153-159
23. Cawthon R.M., Smith K.R., O'Brien E., Sivatchenko A., and Kerber R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361 (2003) 393-395
24. Chang E., and Harley C.B. Telomere length and replicative aging in human vascular tissues. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 11190-11194
25. Chang S., Multani A.S., Cabrera N.G., Naylor M.L., Laud P., Lombard D., Pathak S., Guarente L., and DePinho R.A. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat. Genet. 36 (2004) 877-882
26. Chen Z., Trotman L.C., Shaffer D., Lin H.K., Dotan Z.A., Niki M., Koutcher J.A., Scher H.I., Ludwig T., Gerald W., Cordon-Cardo C., and Pandolfi P.P. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436 (2005) 725-730
27. Cherkas L.F., Aviv A., Valdes A.M., Hunkin J.L., Gardner J.P., Surdulescu G.L., Kimura M., and Spector T.D. The effects of social status on biological aging as measured by white-blood-cell telomere length. Aging Cell 5 (2006) 361-365
28. Chimenti C., Kajstura J., Torella D., Urbanek K., Heleniak H., Colussi C., Di Meglio F., Nadal-Ginard B., Frustaci A., Leri A., Maseri A., and Anversa P. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ. Res. 93 (2003) 604-613
29. Chkhotua A.B., Gabusi E., Altimari A., D'Errico A., Yakubovich M., Vienken J., Stefoni S., Chieco P., Yussim A., and Grigioni W.F. Increased expression of p16(INK4a) and p27(Kip1) cyclin-dependent kinase inhibitor genes in aging human kidney and chronic allograft nephropathy. Am. J. Kidney Dis. 41 (2003) 1303-1313
30. Choi J., Shendrik I., Peacocke M., Peehl D., Buttyan R., Ikeguchi E.F., Katz A.E., and Benson M.C. Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. Urology 56 (2000) 160-166
31. Collado M., Blasco M.A., and Serrano M. Cellular senescence in cancer and aging. Cell 130 (2007) 223-233
32. Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A.J., Barradas M., Benguria A., Zaballos A., Flores J.M., Barbacid M., Beach D., and Serrano M. Tumour biology: senescence in premalignant tumours. Nature 436 (2005) 642
33. Cong Y.S., Fan E., and Wang E. Simultaneous proteomic profiling of four different growth states of human fibroblasts, using amine-reactive isobaric tagging reagents and tandem mass spectrometry. Mech. Ageing Dev. 127 (2006) 332-343
34. Coppe J.P., Kauser K., Campisi J., and Beausejour C.M. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J. Biol. Chem. 281 (2006) 29568-29574
35. Cosme-Blanco W., Shen M.F., Lazar A.J., Pathak S., Lozano G., Multani A.S., and Chang S. Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence. EMBO R. 8 (2007) 497-503
36. Courtois-Cox S., Genther Williams S.M., Reczek E.E., Johnson B.W., McGillicuddy L.T., Johannessen C.M., Hollstein P.E., MacCollin M., and Cichowski K. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10 (2006) 459-472
37. Cox L.S., and Faragher R.G. From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing. Cell. Mol. Life Sci. 64 (2007) 2620-2641
38. Crabbe L., Jauch A., Naeger C.M., Holtgreve-Grez H., and Karlseder J. Telomere dysfunction as a cause of genomic instability in Werner syndrome. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 2205-2210
39. Cristofalo V.J. SA beta Gal staining: biomarker or delusion. Exp. Gerontol. 40 (2005) 836-838
40. Cudre-Mauroux C., Occhiodoro T., Konig S., Salmon P., Bernheim L., and Trono D. Lentivector-mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a duchenne myoblast cell line with long-term genotypic and phenotypic stability. Hum. Gene Ther. 14 (2003) 1525-1533
41. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., and Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426 (2003) 194-198
42. d'Adda di Fagagna F., Teo S.H., and Jackson S.P. Functional links between telomeres and proteins of the DNA-damage response. Genes Dev. 18 (2004) 1781-1799
43. De Meyer T., Rietzschel E.R., De Buyzere M.L., Van Criekinge W., and Bekaert S. Studying telomeres in a longitudinal population based study. Front. Biosci. 13 (2008) 2960-2970
44. Decary S., Mouly V., Hamida C.B., Sautet A., Barbet J.P., and Butler-Browne G.S. Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. Hum. Gene Ther. 8 (1997) 1429-1438
45. Dilley T.K., Bowden G.T., and Chen Q.M. Novel mechanisms of sublethal oxidant toxicity: induction of premature senescence in human fibroblasts confers tumor promoter activity. Exp. Cell Res. 290 (2003) 38-48
46. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 9363-9367
47. Drayton S., and Peters G. Immortalisation and transformation revisited. Curr. Opin. Genet. Dev. 12 (2002) 98-104
48. Drummond M.W., Balabanov S., Holyoake T.L., and Brummendorf T.H. Telomere biology in normal and leukemic hematopoietic stem cells. Stem Cells 25 (2007) 1853-1861
49. Effros, R.B., 2006. Telomerase induction in T cells: a cure for aging and disease? Exp. Gerontol. [Epub ahead of print].
50. Ellison P.T. How old are you now?. Aging Cell 6 (2006) 581
51. Epel E.S., Blackburn E.H., Lin J., Dhabhar F.S., Adler N.E., Morrow J.D., and Cawthon R.M. Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 17312-17315
52. Eriksson M., Brown W.T., Gordon L.B., Glynn M.W., Singer J., Scott L., Erdos M.R., Robbins C.M., Moses T.Y., Berglund P., Dutra A., Pak E., Durkin S., Csoka A.B., Boehnke M., Glover T.W., and Collins F.S. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423 (2003) 293-298
53. Feldser D.M., and Greider C.W. Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 11 (2007) 461-469
54. Fenton M., Barker S., Kurz D.J., and Erusalimsky J.D. Cellular senescence after single and repeated balloon catheter denudations of rabbit carotid arteries. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 220-226
55. Flores I., Cayuela M.L., and Blasco M.A. Effects of telomerase and telomere length on epidermal stem cell behavior. Science (2005) 309
56. Funayama R., Saito M., Tanobe H., and Ishikawa F. Loss of linker histone H1 in cellular senescence. J. Cell Biol. 175 (2006) 869-880
57. Garcia-Cao I., Garcia-Cao M., Tomas-Loba A., Martin-Caballero J., Flores J.M., Klatt P., Blasco M.A., and Serrano M. Increased p53 activity does not accelerate telomere-driven ageing. EMBO R. 7 (2006) 546-552
58. Gil J., and Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell Biol. 7 (2006) 667-677
59. Giri D., and Ittmann M. Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia. Am. J. Pathol. 157 (2000) 249-255
60. Gonos E.S., Derventzi A., Kveiborg M., Agiostratidou G., Kassem M., Clark B.F., Jat P.S., and Rattan S.I. Cloning and identification of genes that associate with mammalian replicative senescence. Exp. Cell Res. 240 (1998) 66-74
61. Halloran P.F., Melk A., and Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J. Am. Soc. Nephrol. 10 (1999) 167-181
62. Hampel B., Wagner M., Teis D., Zwerschke W., Huber L.A., and Jansen-Durr P. Apoptosis resistance of senescent human fibroblasts is correlated with the absence of nuclear IGFBP-3. Aging Cell 4 (2005) 325-330
63. Harley C.B., Futcher A.B., and Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 345 (1990) 458-460
64. Hayflick L. Theories of biological aging. Exp. Gerontol. 20 (1985) 145-159
65. Hayflick L., and Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25 (1961) 585-621
66. Hemann M.T., Strong M.A., Hao L.Y., and Greider C.W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107 (2001) 67-77
67. Hennekam R.C. Hutchinson-Gilford progeria syndrome: review of the phenotype. Am. J. Med. Genet. 140A (2006) 2603-2624
68. Herbig U., Ferreira M., Condel L., Carey D., and Sedivy J.M. Cellular senescence in aging primates. Science 311 (2006) 1257
69. Herbig U., Jobling W.A., Chen B.P., Chen D.J., and Sedivy J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 14 (2004) 501-513
70. Herbig U., and Sedivy J.M. Regulation of growth arrest in senescence: telomere damage is not the end of the story. Mech. Ageing Dev. 127 (2006) 16-24
71. Herbig U., Wei W., Dutriaux A., Jobling W.A., and Sedivy J.M. Real-time imaging of transcriptional activation in live cells reveals rapid up-regulation of the cyclin-dependent kinase inhibitor gene CDKN1A in replicative cellular senescence. Aging Cell 2 (2003) 295-304
72. Hornebeck W. Down-regulation of tissue inhibitor of matrix metalloprotease-1 (TIMP-1) in aged human skin contributes to matrix degradation and impaired cell growth and survival. Pathol. Biol. 51 (2003) 569-573
73. Hornsby P.J. Short telomeres: cause or consequence of aging?. Aging Cell 6 (2006) 577-578
74. Huang S., Risques R.A., Martin G.M., Rabinovitch P.S., and Oshima J. Accelerated telomere shortening and replicative senescence in human fibroblasts overexpressing mutant and wild-type lamin A. Exp. Cell Res. 314 (2008) 82-91
75. Itahana K., Campisi J., and Dimri G.P. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol. Biol. 371 (2007) 21-31
76. Janzen V., Forkert R., Fleming H.E., Saito Y., Waring M.T., Dombkowski D.M., Cheng T., DePinho R.A., Sharpless N.E., and Scadden D.T. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443 (2006) 421-426
77. Jenkins G. Molecular mechanisms of skin ageing. Mech. Ageing Dev. 123 (2002) 801-810
78. Jeyapalan J.C., Ferreira M., Sedivy J.M., and Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech. Ageing Dev. 128 (2007) 36-44
79. Joosten S.A., van Ham V., Nolan C.E., Borrias M.C., Jardine A.G., Shiels P.G., van Kooten C., and Paul L.C. Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. Am. J. Pathol. 162 (2003) 1305-1312
80. Kajstura J., Pertoldi B., Leri A., Beltrami C.A., Deptala A., Darzynkiewicz Z., and Anversa P. Telomere shortening is an in vivo marker of myocyte replication and aging. Am. J. Pathol. 156 (2000) 813-819
81. Keyes W.M., and Mills A.A. p63: a new link between senescence and aging. Cell Cycle 5 (2006) 260-265
82. Keyes W.M., Wu Y., Vogel H., Guo X., Lowe S.W., and Mills A.A. p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev. 19 (2005) 1986-1999
83. Kim W.Y., and Sharpless N.E. The regulation of INK4/ARF in cancer and aging. Cell 127 (2006) 265-275
84. Kimura, M., Barbieri, M., Gardner, J.P., Skurnick, J., Cao, X., van Riel, N., Rizzo, M.R., Paolisso, G., Aviv, A., 2007. Leukocytes of exceptionally old persons display ultra-short telomeres. Am. J. Physiol. Regul. Integr. Comp. Physiol. [Epub ahead of print].
85. Kirkwood T.B., and Austad S.N. Why do we age?. Nature 408 (2000) 233-238
86. Krishnamurthy J., Ramsey M.R., Ligon K.L., Torrice C., Koh A., Bonner-Weir S., and Sharpless N.E. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443 (2006) 453-457
87. Krishnamurthy J., Torrice C., Ramsey M.R., Kovalev G.I., Al-Regaiey K., Su L., and Sharpless N.E. Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114 (2004) 1299-1307
88. Krtolica A., and Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int. J. Biochem. Cell Biol. 34 (2002) 1401-1414
89. Krtolica A., Parrinello S., Lockett S., Desprez P.Y., and Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12072-12077
90. Ksiazek K., Passos J.F., Olijslagers S., Saretzki G., Martin-Ruiz C., and von Zglinicki T. Premature senescence of mesothelial cells is associated with non-telomeric DNA damage. Biochem. Biophys. Res. Commun. 362 (2007) 707-711
91. Kudlow B.A., Kennedy B.K., and Monnat R.J.J. Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases. Nat. Rev. Mol. Cell Biol. 8 (2007) 394-404
92. Kuh D. A life course perspective on telomere length and social inequalities in aging. Aging Cell 6 (2006) 579-580
93. Lansdorp P.M. Stress, social rank and leukocyte telomere length. Aging Cell 6 (2006) 583-584
94. Lazzerini Denchi E., Attwooll C., Pasini D., and Helin K. Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol. Cell Biol. 25 (2005) 2660-2672
95. Le Guilly Y., Simon M., Lenoir P., and Bourel M. Long-term culture of human adult liver cells: morphological changes related to in vitro senescence and effect of donor's age on growth potential. Gerontologia 19 (1973) 303-313
96. Lebel M., and Leder P. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 13097-13102
97. Lechel A., Satyanarayana A., Ju Z., Plentz R.R., Schaetzlein S., Rudolph C., Wilkens L., Wiemann S.U., Saretzki G., Malek N.P., Manns M.P., Buer J., and Rudolph K.L. The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo. EMBO R. 6 (2005) 275-281
98. Lee B.Y., Han J.A., Im J.S., Morrone A., Johung K., Goodwin E.C., Kleijer W.J., DiMaio D., and Hwang E.S. Senescence-associated β-galactosidase is lysosomal β-galactosidase. Aging Cell 5 (2006) 187-195
99. Lessard J., and Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423 (2003) 255-260
100. Lewis J.L., Chinswangwatanakul W., Zheng B., Marley S.B., Nguyen D.X., Cross N.C., Banerji L., Glassford J., Thomas N.S., Goldman J.M., Lam E.W., and Gordon M.Y. The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells. Blood 97 (2001) 2604-2610
101. Marcotte R., Lacelle C., and Wang E. Senescent fibroblasts resist apoptosis by downregulating caspase-3. Mech. Ageing Dev. 125 (2004) 777-783
102. Martens J.W., Sieuwerts A.M., Bolt-deVries J., Bosma P.T., Swiggers S.J., Klijn J.G., and Foekens J.A. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression. Thromb. Haemost. 89 (2003) 393-404
103. Martin G.M., Sprague C.A., and Epstein C.J. Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. Lab. Invest. 23 (1970) 86-92
104. Matsumura T., Zerrudo Z., and Hayflick L. Senescent human diploid cells in culture: survival, DNA synthesis and morphology. J. Gerontol. 34 (1979) 328-334
105. Matthews C., Gorenne I., Scott S., Figg N., Kirkpatrick P., Ritchie A., Goddard M., and Bennett M. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ. Res. 99 (2006) 156-164
106. Melk A., Ramassar V., Helms L.M., Moore R., Rayner D., Solez K., and Halloran P.F. Telomere shortening in kidneys with age. J. Am. Soc. Nephrol. 11 (2000) 444-453
107. Meng A., Wang Y., Van Zant G., and Zhou D. Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. Cancer Res. 63 (2003) 5414-5419
108. Michaloglou C., Vredeveld L.C., Soengas M.S., Denoyelle C., Kuilman T., van der Horst C.M., Majoor D.M., Shay J.W., Mooi W.J., and Peeper D.S. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436 (2005) 720-724
109. Minamino T., and Komuro I. Role of telomeres in vascular senescence. Front. Biosci. 13 (2008) 2971-2979
110. Minamino T., Miyauchi H., Yoshida T., Ishida Y., Yoshida H., and Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105 (2002) 1541-1544
111. Molofsky A.V., Pardal R., Iwashita T., Park I.K., Clarke M.F., and Morrison S.J. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425 (2003) 962-967
112. Molofsky A.V., Slutsky S.G., Joseph N.M., He S., Pardal R., Krishnamurthy J., Sharpless N.E., and Morrison S.J. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443 (2006) 448-452
113. Multani A.S., and Chang S. WRN at telomeres: implications for aging and cancer. J. Cell Sci. 120 (2007) 713-721
114. Narita M., Nunez S., Heard E., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., and Lowe S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113 (2003) 703-716
115. Nielsen G.P., Stemmer-Rachamimov A.O., Shaw J., Roy J.E., Koh J., and Louis D.N. Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues. Lab. Invest. 79 (1999) 1137-1143
116. Ogami M., Ikura Y., Ohsawa M., Matsuo T., Kayo S., Yoshimi N., Hai E., Shirai N., Ehara S., Komatsu R., Naruko T., and Ueda M. Telomere shortening in human coronary artery diseases. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 546-550
117. Ohtani N., Zebedee Z., Huot T.J., Stinson J.A., Sugimoto M., Ohashi Y., Sharrocks A.D., Peters G., and Hara E. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409 (2001) 1067-1070
118. Okuda K., Khan M.Y., Skurnick J., Kimura M., Aviv H., and Aviv A. Telomere attrition of the human abdominal aorta: relationships with age and atherosclerosis. Atherosclerosis 152 (2000) 391-398
119. Olovnikov A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 41 (1973) 181-190
120. Panossian L.A., Porter V.R., Valenzuela H.F., Zhu X., Reback E., Masterman D., Cummings J.L., and Effros R.B. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol. Aging 24 (2003) 77-84
121. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J., and Clarke M.F. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423 (2003) 302-305
122. Parrinello S., Coppe J.P., Krtolica A., and Campisi J. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 118 (2005) 485-496
123. Pascal T., Debacq-Chainiaux F., Chretien A., Bastin C., Dabee A.F., Bertholet V., Remacle J., and Toussaint O. Comparison of replicative senescence and stress-induced premature senescence combining differential display and low-density DNA arrays. FEBS Lett. 579 (2005) 3651-3659
124. Passegué E., and Wagner E.F. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J. 19 (2000) 2969-2979
125. Pignolo R.J., Martin B.G., Horton J.H., Kalbach A.N., and Cristofalo V.J. The pathway of cell senescence: WI-38 cells arrest in late G1 and are unable to traverse the cell cycle from a true G0 state. Exp. Gerontol. 33 (1998) 67-80
126. Pignolo R.J., Rotenberg M.O., and Cristofalo V.J. Alterations in contact and density-dependent arrest state in senescent WI-38 cells. In Vitro Cell Dev. Biol. Anim. 30A (1994) 471-476
127. Price J.S., Waters J.G., Darrah C., Pennington C., Edwards D.R., Donell S.T., and Clark I.M. The role of chondrocyte senescence in osteoarthritis. Aging Cell 1 (2002) 57-65
128. Ressler S., Bartkova J., Niederegger H., Bartek J., Scharffetter-Kochanek K., Jansen-Durr P., and Wlaschek M. p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 5 (2006) 379-389
129. Rheinwald J.G., and Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6 (1975) 331-343
130. Roberson R.S., Kussick S.J., Vallieres E., Chen S.Y., and Wu D.Y. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers. Cancer Res. 65 (2005) 2795-2803
131. Roninson I.B. Tumor cell senescence in cancer treatment. Cancer Res. 63 (2003) 2705-2715
132. Rose M.R. The Evolutionary Biology of Aging (1991), Oxford University Press, Oxford
133. Sager R. Senescence as a mode of tumor suppression. Environ. Health Perspect. 93 (1991) 59-62
134. Saito H., and Papaconstantinou J. Age-associated differences in cardiovascular inflammatory gene induction during endotoxic stress. J. Biol. Chem. 276 (2001) 29307-29312
135. Salk D. Can we learn about aging from a study of Werner's syndrome?. J. Am. Geriatr. Soc. 30 (1982) 334-339
136. Sarin K.Y., and Artandi S.E. Aging, graying and loss of melanocyte stem cells. Stem Cell Rev. 3 (2007) 212-217
137. Satyanarayana A., Wiemann S.U., Buer J., Lauber J., Dittmar K.E., Wustefeld T., Blasco M.A., Manns M.P., and Rudolph K.L. Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J. 22 (2003) 4003-4013
138. Schmitt C.A., Fridman J.S., Yang M., Lee S., Baranov E., Hoffman R.M., and Lowe S.W. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109 (2002) 335-346
139. Schneider E.L., and Mitsui Y. The relationship between in vitro cellular aging and in vivo human age. Proc. Natl. Acad. Sci. U.S.A. 73 (1976) 3584-3588
140. Schwarze S.R., DePrimo S.E., Grabert L.M., Fu V.X., Brooks J.D., and Jarrard D.F. Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. J. Biol. Chem. 277 (2002) 14877-14883
141. Sedelnikova, O.A., Horikawa, I., Redon, C., Nakamura, A., Zimonjic, D.B., Popescu, N.C., Bonner, W.M., 2007. Delayed kinetics of DNA double-strand break processing in normal and pathological aging. Aging Cell [Epub ahead of print].
142. Sedelnikova O.A., Horikawa I., Zimonjic D.B., Popescu N.C., Bonner W.M., and Barrett J.C. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat. Cell Biol. 6 (2004) 168-170
143. Sedivy J.M., Munoz-Najar U.M., Jeyapalan J.C., and Campisi J. Cellular senescence: a link between tumor suppression and organismal aging?. In: Guarente L., and Partridge L. (Eds). The Molecular Biology of Aging (2007), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
144. Semov A., Marcotte R., Semova N., Ye X., and Wang E. Microarray analysis of E-box binding-related gene expression in young and replicatively senescent human fibroblasts. Anal. Biochem. 302 (2002) 38-51
145. Serrano M., Lin A.W., McCurrach M.E., Beach D., and Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 (1997) 593-602
146. Seshadri T., and Campisi J. Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. Science 247 (1990) 205-209
147. Severino J., Allen R.G., Balin S., Balin A., and Cristofalo V.J. Is beta-galactosidase staining a marker of senescence in vitro and in vivo?. Exp. Cell Res. 257 (2000) 162-171
148. Sfeir A.J., Chai W., Shay J.W., and Wright W.E. Telomere end processing: the terminal nucleotides of human chromosomes. Mol. Cell 18 (2005) 131-138
149. Shelton D.N., Chang E., Whittier P.S., Choi D., and Funk W.D. Microarray analysis of replicative senescence. Curr. Biol. 9 (1999) 939-945
150. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13 (1999) 1501-1512
151. Stehbens W.E., Wakefield S.J., Gilbert-Barness E., Olson R.E., and Ackerman J. Histological and ultrastructural features of atherosclerosis in progeria. Cardiovasc. Pathol. 8 (1999) 29-39
152. Takai H., Smogorzewska A., and de Lange T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13 (2003) 1549-1556
153. te Poele R.H., Okorokov A.L., Jardine L., Cummings J., and Joel S.P. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62 (2002) 1876-1883
154. Torella D., Rota M., Nurzynska D., Musso E., Monsen A., Shiraishi I., Zias E., Walsh K., Rosenzweig A., Sussman M.A., Urbanek K., Nadal-Ginard B., Kajstura J., Anversa P., and Leri A. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ. Res. 94 (2004) 514-524
155. Trougakos I.P., Saridaki A., Panayotou G., and Gonos E.S. Identification of differentially expressed proteins in senescent human embryonic fibroblasts. Mech. Ageing Dev. 127 (2006) 88-92
156. Tsakiri K.D., Cronkhite J.T., Kuan P.J., Xing C., Raghu G., Weissler J.C., Rosenblatt R.L., Shay J.W., and Garcia C.K. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 7552-7557
157. Valdes A.M., Andrew T., Gardner J.P., Kimura M., Oelsner E., Cherkas L.F., Aviv A., and Spector T.D. Obesity, cigarette smoking, and telomere length in women. Lancet 366 (2005) 662-664
158. Vasile E., Tomita Y., Brown L.F., Kocher O., and Dvorak H.F. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 15 (2001) 458-466
159. Ventura A., Kirsch D.G., McLaughlin M.E., Tuveson D.A., Grimm J., Lintault L., Newman J., Reczek E.E., Weissleder R., and Jacks T. Restoration of p53 function leads to tumour regression in vivo. Nature 445 (2007) 661-665
160. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 27 (2002) 339-344
161. von Zglinicki T., and Martin-Ruiz C.M. Telomeres as biomarkers for ageing and age-related diseases. Curr. Mol. Med. 5 (2005) 197-203
162. von Zglinicki T., Saretzki G., Docke W., and Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?. Exp. Cell Res. 220 (1995) 186-193
163. Vulliamy T., and Dokal I. Dyskeratosis congenita. Semin. Hematol. 43 (2006) 157-166
164. Vulliamy T., Marrone A., Szydlo R., Walne A., Mason P.J., and Dokal I. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat. Genet. 36 (2004) 447-449
165. Williams G.C. Pleiotrophy, natural selection and the evolution of senescence. Evolution 11 (1957) 398-411
166. Wright W.E., and Shay J.W. Historical claims and current interpretations of replicative aging. Nat. Biotechnol. 20 (2002) 682-688
167. Xie L., Tsaprailis G., and Chen Q.M. Proteomic identification of insulin-like growth factor-binding protein-6 induced by sublethal H2O2 stress from human diploid fibroblasts. Mol. Cell. Proteomics 4 (2005) 1273-1283
168. Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., Cordon-Cardo C., and Lowe S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007) 656-660
169. Yamaguchi H., Calado R.T., Ly H., Kajigaya S., Baerlocher G.M., Chanock S.J., Lansdorp P.M., and Young N.S. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N. Engl. J. Med. 352 (2005) 1413-1424
170. Yang N.C., and Hu M.L. The limitations and validities of senescence associated-beta-galactosidase activity as an aging marker for human foreskin fibroblast Hs68 cells. Exp. Gerontol. 40 (2005) 813-819
171. Ye X., Zerlanko B., Kennedy A., Banumathy G., Zhang R., and Adams P.D. Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells. Mol. Cell 27 (2007) 183-196
172. Yegorov Y.E., Akimov S.S., Hass R., Zelenin A.V., and Prudovsky I.A. Endogenous beta-galactosidase activity in continuously nonproliferating cells. Exp. Cell Res. 243 (1998) 207-211
173. Yogev, O., Anzi, S., Inoue, K., E S., 2006. Induction of transcriptionally active Jun proteins regulates drug-induced senescence. J. Biol. Chem. 281, 34475-34483.
174. Yoon I.K., Kim H.K., Kim Y.K., Song I.H., Kim W., Kim S., Baek S.H., Kim J.H., and Kim J.R. Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technology. Exp. Gerontol. 39 (2004) 1369-1378
175. Yu C.E., Oshima J., Fu Y.H., Wijsman E.M., Hisama F., Alisch R., Matthews S., Nakura J., Miki T., Ouais S., Martin G.M., Mulligan J., and Schellenberg G.D. Positional cloning of the Werner's syndrome gene. Science 272 (1996) 258-262
176. Zdanov S., Debacq-Chainiaux F., Remacle J., and Toussaint O. Identification of p38MAPK-dependent genes with changed transcript abundance in H2O2-induced premature senescence of IMR-90 hTERT human fibroblasts. FEBS Lett. 580 (2006) 6455-6463
177. Zhang H., Pan K.H., and Cohen S.N. Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 3251-3256
178. Zhang R., Chen W., and Adams P.D. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol. Cell Biol. 27 (2007) 2343-2358
179. Zhang R., Poustovoitov M.V., Ye X., Santos H.A., Chen W., Daganzo S.M., Erzberger J.P., Serebriiskii I.G., Canutescu A.A., Dunbrack R.L., Pehrson J.R., Berger J.M., Kaufman P.D., and Adams P.D. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev. Cell 8 (2005) 19-30
180. Zhu C.H., Mouly V., Cooper R.N., Mamchaoui K., Bigot A., Shay J.W., Di Santo J.P., Butler-Browne G.S., and Wright W.E. Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell 6 (2007) 515-523
181. Zindy F., Quelle D.E., Roussel M.F., and Sherr C.J. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15 (1997) 203-211